TherapeuticsMD Receives Notice of Allowance for Patent Covering TX 12-001-HR

By: Benzinga
TherapeuticsMD (NYSE: TXMD ) announced today that it received a Notice of Allowance from the U.S. Patent and Trademark Office pertaining to its U.S. Patent Application 13/684,002 - "Natural Combination Hormone
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.